Clinical Video Shorts

Omega-3 and Omega-6, Blood Levels And Coronary Heart Disease Risk/Benefit Controversy

Robert Superko, MD and Michael Caulfield, PhD, discuss the current clinical research on the use of Omega-3 & 6 supplementation and their link to decreased risk of cardiovascular events, including sudden cardiac death. They also discuss the clinical management of patients including the use of the Omega-3 & 6, Fatty Acid laboratory test as a marker of cardiovascular risk.


H. Robert Superko, MD, FACC, FAHA, FAACVPR

Academic Associate and Senior Medical Advisor

Quest Diagnostics


Michael P. Caulfield, PhD

Senior Scientific Director,

Endocrinology and Cardiovascular Disease

Quest Diagnostics, Nichols Institute

( back to Cardiovascular Short-Subjects )